Terms: = Brain cancer AND SYK, P43405, 6850, ENSG00000165025 AND Treatment
10 results:
1. syk-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.
Zhou J; Zhang XC; Xue S; Dai M; Wang Y; Peng X; Chen J; Wang X; Shen Y; Qin H; Chen B; Zheng Y; Gao X; Xie Z; Ding J; Jiang H; Wu YL; Geng M; Ai J
Signal Transduct Target Ther; 2023 May; 8(1):185. PubMed ID: 37183231
[TBL] [Abstract] [Full Text] [Related]
2. RNA Sequencing in Hypoxia-Adapted T98G Glioblastoma Cells Provides Supportive Evidence for IRE1 as a Potential Therapeutic Target.
White BE; Liu Y; Hakonarson H; Buono RJ
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107600
[TBL] [Abstract] [Full Text] [Related]
3. A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
Kling MJ; Kesherwani V; Mishra NK; Alexander G; McIntyre EM; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
J Exp Clin Cancer Res; 2022 Nov; 41(1):321. PubMed ID: 36357906
[TBL] [Abstract] [Full Text] [Related]
4. American Joint Committee on cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract] [Full Text] [Related]
5. Lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: Implication of reducing cancer recurrence risk.
Hu C; Iwasaki M; Liu Z; Wang B; Li X; Lin H; Li J; Li JV; Lian Q; Ma D
J Adv Res; 2021 Jul; 31():1-12. PubMed ID: 34194828
[TBL] [Abstract] [Full Text] [Related]
6. [The relationship between hypermethylation of syk gene promoter and medulloblastoma cell invasion and metastasis].
Ji HL; Shi PF; Zhou J; Mao TM; Luo YK; Chen X; Zhou KY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Feb; 32(2):132-136. PubMed ID: 29931864
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of atherosclerosis after cessation of cabergoline therapy in patients with prolactinoma.
Doğan BA; Arduç A; Tuna MM; Nasıroğlu NI; Işık S; Berker D; Güler S
Anatol J Cardiol; 2016 Jun; 16(6):440-7. PubMed ID: 26680550
[TBL] [Abstract] [Full Text] [Related]
8. A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta.
Lee HM; Kim KS; Kim J
Cell Immunol; 2014 Jul; 290(1):52-61. PubMed ID: 24879062
[TBL] [Abstract] [Full Text] [Related]
9. The ERBB3 receptor in cancer and cancer gene therapy.
Sithanandam G; Anderson LM
Cancer Gene Ther; 2008 Jul; 15(7):413-48. PubMed ID: 18404164
[TBL] [Abstract] [Full Text] [Related]
10. Structure-based design of novel anticancer agents.
Uckun FM; Sudbeck EA; Mao C; Ghosh S; Liu XP; Vassilev AO; Navara CS; Narla RK
Curr Cancer Drug Targets; 2001 May; 1(1):59-71. PubMed ID: 12188892
[TBL] [Abstract] [Full Text] [Related]
